Genoveva Murillo, Ph.D. - Publications

Affiliations: 
2000 University of Illinois at Chicago, Health Sciences Center, Chicago, IL 60612, United States 
Area:
Nutrition, Oncology

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Singh S, Murillo G, Richner J, Singh SP, Berleth E, Kumar V, Mehta R, Ramiya V, Parihar AS. A Broad-Based Characterization of a Cell-Penetrating, Single Domain Camelid Bi-Specific Antibody Monomer That Targets STAT3 and KRAS Dependent Cancers. International Journal of Molecular Sciences. 23. PMID 35886918 DOI: 10.3390/ijms23147565  0.377
2019 Murillo G, Peng X, Muzzio M, Bosland MC, Glaze ER, Suen C, McCormick DL. Abstract 2730: Exceptional activity of ARN-509 (apalutamide) in prostate cancer prevention in rats Cancer Research. 79: 2730-2730. DOI: 10.1158/1538-7445.Am2019-2730  0.346
2019 Singh S, Murillo G, Singh A, Singh S, Parihar M, Singh A, Mehta R, Parihar A. Abstract 1544: Cell penetrating single domain antibody (sdAb) SBT-100 binds KRAS and inhibits growth of human cancers with KRAS activating mutations Cancer Research. 79: 1544-1544. DOI: 10.1158/1538-7445.Am2019-1544  0.434
2018 Singh S, Murillo G, Singh A, Singh S, Parihar M, Mehta R, Singh A, Parihar A. Abstract 5436: Novel single-domain antibody (sdAb), SBT-100, localizes in the cytoplasm to inhibit IL-6 mediated P-STAT3 nuclear translocation in cancer cells Cancer Research. 78: 5436-5436. DOI: 10.1158/1538-7445.Am2018-5436  0.419
2018 Tsimafeyeu I, Byakhov M, Mihaljević VB, Padovan J, Murillo G, Dragun N, Gavrilova E, Tjulandin S. Abstract B084: Preclinical pharmacokinetic evaluation of alofanib for cancer treatment Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-B084  0.359
2017 Singh S, Murillo G, Singh A, Singh S, Parihar MS, Singh AH, Mehta R, Parihar AS. Effect of KRAS and P-STAT3 inhibition by SBT-100 on gemcitabine and pancreatic cancer growth in vivo. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E15727  0.457
2017 Singh S, Murillo G, Singh A, Singh S, Parihar MS, Singh AH, Mehta R, Parihar AS. Single domain antibody (SBT-100) crosses the blood brain barrier (BBB) and inhibits human glioblastoma by selectively targeting KRAS and P-STAT3. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E13547  0.331
2017 Singh S, Murillo G, Chen D, Singh A, Mehta R, Parihar A. Abstract P6-12-13: Single domain antibody (SBT-100) inhibits growth of human HER2+ and triple negative breast cancers (TNBC) in xenografts by binding STAT3 and P-STAT3 Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P6-12-13  0.498
2017 Singh S, Murillo G, Rom A, Singh A, Singh S, Parihar M, Chen D, Mehta R, Baker R, Singh A, Parihar AS. Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers Cancer Research. 77: 4699-4699. DOI: 10.1158/1538-7445.Am2017-4699  0.49
2016 Singh S, Murillo G, Mehta R, Chen D, Singh A, Singh S, Singh A, Parihar AS. A novel single domain antibody (sdAb) SBT-100 targeting intracellular STAT3 to inhibit major subtypes of human breast cancer. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E14000  0.44
2016 Singh S, Murillo G, Mehta R, Chen D, Singh A, Singh S, Singh A, Parihar AS. A novel single domain antibody (sdAb) SBT-100 to target intracellular STAT3 to affect growth and regression of human triple negative breast cancer (TNBC) cells. Journal of Clinical Oncology. 34: 1083-1083. DOI: 10.1200/Jco.2016.34.15_Suppl.1083  0.42
2015 Tsimafeyeu I, Byakhov M, Mihaljević VB, Padovan J, Murillo G, Tjulandin S. Abstract B146: Preclinical pharmacokinetic studies of RPT835, an allosteric FGFR2 inhibitor Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B146  0.351
2014 Mazué F, Delmas D, Murillo G, Saleiro D, Limagne E, Latruffe N. Differential protective effects of red wine polyphenol extracts (RWEs) on colon carcinogenesis. Food & Function. 5: 663-70. PMID 24569685 DOI: 10.1039/C3Fo60417A  0.435
2013 Mehta R, Katta H, Alimirah F, Patel R, Murillo G, Peng X, Muzzio M, Mehta RG. Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells. Plos One. 8: e65113. PMID 23762292 DOI: 10.1371/Journal.Pone.0065113  0.436
2013 Mehta RR, Katta H, Kalra A, Patel R, Gupta A, Alimirah F, Murillo G, Peng X, Unni A, Muzzio M, Mehta RG. Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cells. Clinical & Experimental Metastasis. 30: 855-66. PMID 23645347 DOI: 10.1007/S10585-013-9585-6  0.462
2013 Mehta RG, Peng X, Alimirah F, Murillo G, Mehta R. Vitamin D and breast cancer: emerging concepts. Cancer Letters. 334: 95-100. PMID 23142286 DOI: 10.1016/J.Canlet.2012.10.034  0.403
2013 Gupta A, Mehta R, Alimirah F, Peng X, Murillo G, Wiehle R, Mehta RG. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 133: 30-42. PMID 22939887 DOI: 10.1016/J.Jsbmb.2012.08.004  0.46
2012 Saleiro D, Murillo G, Benya RV, Bissonnette M, Hart J, Mehta RG. Estrogen receptor-β protects against colitis-associated neoplasia in mice. International Journal of Cancer. Journal International Du Cancer. 131: 2553-61. PMID 22488198 DOI: 10.1002/Ijc.27578  0.36
2012 Peng X, Tiwari N, Roy S, Yuan L, Murillo G, Mehta RR, Benya RV, Mehta RG. Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D₃ in human colon cancer cells. The Journal of Endocrinology. 212: 207-15. PMID 22068926 DOI: 10.1530/Joe-11-0305  0.381
2012 Kalra AP, Gupta A, Patel R, Katta H, Hawthorne M, Murillo G, Mehta R, Mehta R. Abstract 3829: Inhibition of breast cancer metastasis by deguelin in an experimental model Cancer Research. 72: 3829-3829. DOI: 10.1158/1538-7445.Am2012-3829  0.479
2012 Saleiro D, Murillo G, Hawthorne M, Mehta R. Abstract 1631: Protection of colon carcinogenesis by estrogen receptor-beta may involve regulation of angiogenesis and invasion specific signaling molecules Cancer Research. 72: 1631-1631. DOI: 10.1158/1538-7445.Am2012-1631  0.396
2011 Alimirah F, Peng X, Murillo G, Mehta RG. Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. Plos One. 6: e16024. PMID 21283672 DOI: 10.1371/Journal.Pone.0016024  0.417
2011 Saleiro D, Murillo G, Mutreja K, Hawthorne M, Mehta RG. Abstract 5590: Role of estrogen receptor-beta in colitis-associated cancer Cancer Research. 71: 5590-5590. DOI: 10.1158/1538-7445.Am2011-5590  0.391
2011 Peng X, Alimirah F, Roy S, Yuan L, Murillo G, Mehta RR, Mehta RG. Abstract 456: 25-Hydroxyvitamin D3 inhibits clonogenic growth and regulates expression of multiple cytokines/chemokines in co-culture of colon cancer and macrophage-like THP-1 cells Cancer Research. 71: 456-456. DOI: 10.1158/1538-7445.Am2011-456  0.441
2011 Kakarala M, Dubey SK, Dobry CJ, Peng X, Murillo G, Parikh SR, Amarasinghe C, Mehta R, Brenner DE. Abstract 1842: Vitamin D compounds induce BRCA1 expression and inhibit breast stem cells Cancer Research. 71: 1842-1842. DOI: 10.1158/1538-7445.Am2011-1842  0.415
2011 Gupta A, Mehta R, Alimirah F, Murillo G, Peng X, Wiehle R. P2-17-05: Antiprogestin Proellex Suppresses Proliferation of Aromatase Overexpressing and Letrozole Resistant T47D Breast Cancer Cells. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-17-05  0.463
2010 Saleiro D, Murillo G, Lubahn DB, Kopelovich L, Korach KS, Mehta RG. Enhanced induction of mucin-depleted foci in estrogen receptor {beta} knockout mice. Cancer Prevention Research (Philadelphia, Pa.). 3: 1198-204. PMID 20716634 DOI: 10.1158/1940-6207.Capr-10-0044  0.34
2010 Peng X, Vaishnav A, Murillo G, Alimirah F, Torres KE, Mehta RG. Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells. Journal of Cellular Biochemistry. 110: 1324-33. PMID 20564226 DOI: 10.1002/Jcb.22646  0.354
2010 Mehta RG, Murillo G, Naithani R, Peng X. Cancer chemoprevention by natural products: how far have we come? Pharmaceutical Research. 27: 950-61. PMID 20238150 DOI: 10.1007/S11095-010-0085-Y  0.381
2010 Murillo G, Nagpal V, Tiwari N, Benya RV, Mehta RG. Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer. The Journal of Steroid Biochemistry and Molecular Biology. 121: 403-7. PMID 20214986 DOI: 10.1016/J.Jsbmb.2010.03.009  0.391
2010 Saleiro D, Murillo G, Kopelovich L, Mehta RG. Abstract 940: Mucin depleted foci as a biomarker for colon precancerous lesions in estrogen receptor β knockout mice Cancer Research. 70: 940-940. DOI: 10.1158/1538-7445.Am10-940  0.371
2010 Kanade GG, Nathani R, Huma L, Mehta RG, Murillo G. Abstract 5694: Zapotin mediates its action by inducing p53 in wild-type p53 positive human lung cancer cells Cancer Research. 70: 5694-5694. DOI: 10.1158/1538-7445.Am10-5694  0.422
2010 Gupta A, Peng X, Murillo G, Mehta RR, Wiehle R, Mehta RG. Abstract 5691: Significance of combination treatment of antiprogestin and aromatase inhibitors in aromatase overexpressing T47D breast cancer cells Cancer Research. 70: 5691-5691. DOI: 10.1158/1538-7445.Am10-5691  0.439
2009 Murillo G, Peng X, Torres KE, Mehta RG. Deguelin inhibits growth of breast cancer cells by modulating the expression of key members of the Wnt signaling pathway. Cancer Prevention Research (Philadelphia, Pa.). 2: 942-50. PMID 19861542 DOI: 10.1158/1940-6207.Capr-08-0232  0.473
2008 Hooshmand S, Khalil DA, Murillo G, Singletary K, Kamath SK, Arjmandi BH. The combination of genistin and ipriflavone prevents mammary tumorigenesis and modulates lipid profile. Clinical Nutrition (Edinburgh, Scotland). 27: 643-8. PMID 18571816 DOI: 10.1016/J.Clnu.2008.04.012  0.341
2008 Murillo G, Naithani R, Mehta RG. Efficacy of herbal products in colorectal cancer prevention Current Colorectal Cancer Reports. 4: 34-42. DOI: 10.1007/S11888-008-0007-0  0.414
2007 Murillo G, Hirschelman WH, Ito A, Moriarty RM, Kinghorn AD, Pezzuto JM, Mehta RG. Zapotin, a phytochemical present in a Mexican fruit, prevents colon carcinogenesis. Nutrition and Cancer. 57: 28-37. PMID 17516860 DOI: 10.1080/01635580701268097  0.438
2007 Murillo G, Matusiak D, Benya RV, Mehta RG. Chemopreventive efficacy of 25-hydroxyvitamin D3 in colon cancer. The Journal of Steroid Biochemistry and Molecular Biology. 103: 763-7. PMID 17257827 DOI: 10.1016/J.Jsbmb.2006.12.074  0.413
2006 Choi JK, Murillo G, Su BN, Pezzuto JM, Kinghorn AD, Mehta RG. Ixocarpalactone A isolated from the Mexican tomatillo shows potent antiproliferative and apoptotic activity in colon cancer cells. The Febs Journal. 273: 5714-23. PMID 17212786 DOI: 10.1111/J.1742-4658.2006.05560.X  0.448
2005 Matusiak D, Murillo G, Carroll RE, Mehta RG, Benya RV. Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 2370-6. PMID 16214919 DOI: 10.1158/1055-9965.Epi-05-0257  0.402
2005 Murillo G, Mehta RG. Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5. The Journal of Steroid Biochemistry and Molecular Biology. 97: 129-36. PMID 16051482 DOI: 10.1016/J.Jsbmb.2005.06.008  0.36
2005 Chow AW, Murillo G, Yu C, Van Breemen RB, Boddie AW, Pezzuto JM, Das Gupta TK, Mehta RG. Resveratrol inhibits rhabdomyosarcoma cell proliferation European Journal of Cancer Prevention. 14: 351-356. PMID 16030425 DOI: 10.1097/00008469-200508000-00007  0.396
2003 Gentile MS, Vasu C, Green A, Murillo G, Das Gupta TK, Constantinou AI, Prabhakar BS, Salti GI. Targeting colon cancer cells with genistein-17.1A immunoconjugate. International Journal of Oncology. 22: 955-9. PMID 12684659 DOI: 10.3892/Ijo.22.5.955  0.399
2003 Murillo G, Kosmeder JW, Pezzuto JM, Mehta RG. Deguelin suppresses the formation of carcinogen-induced aberrant crypt foci in the colon of CF-1 mice. International Journal of Cancer. 104: 7-11. PMID 12532413 DOI: 10.1002/Ijc.10901  0.354
2003 Murillo G, Salti GI, Kosmeder JW, Pezzuto JM, Mehta RG. Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest. European Journal of Cancer (Oxford, England : 1990). 38: 2446-54. PMID 12460790 DOI: 10.1016/S0959-8049(02)00192-2  0.434
2001 Murillo G, Mehta RG. Cruciferous Vegetables and Cancer Prevention Nutrition and Cancer. 41: 17-28. PMID 12094621 DOI: 10.1080/01635581.2001.9680607  0.395
1999 Kamath SK, Murillo G, Chatterton RT, Hussain EA, Amin D, Mortillaro E, Peterson CT, Alekel DL. Breast cancer risk factors in two distinct ethnic groups: Indian and Pakistani vs. American premenopausal women Nutrition and Cancer. 35: 16-26. PMID 10624702 DOI: 10.1207/S1532791416-26  0.329
Show low-probability matches.